Koninklijke Philips (PHG) Non-Current Deffered Revenue (2017 - 2026)

Koninklijke Philips' (PHG) quarterly Non-Current Deffered Revenue came in at $512.8 million in Q1 2026, up 18.32% year-on-year from $433.4 million in Q1 2025, and down 3.82% quarter-over-quarter from $533.1 million in Q4 2025.

Koninklijke Philips (PHG) Non-Current Deffered Revenue (2017 - 2026) Analysis & Trends

Koninklijke Philips' Non-Current Deffered Revenue history runs 10 years deep, the most recent figure standing at $512.8 million for Q1 2026.

  • On a quarterly basis, Non-Current Deffered Revenue rose 18.32% year-over-year to $512.8 million in Q1 2026; TTM through Mar 2026 was $512.8 million, a 18.32% increase from a year earlier, with the FY2025 full-year figure at $533.1 million, up 15.76% from the prior year.
  • Non-Current Deffered Revenue declined to $512.8 million in Q1 2026 per PHG's latest filing, from $533.1 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $537.9 million in Q2 2023 and bottomed at $433.4 million in Q1 2025.
  • The 5-year median for Non-Current Deffered Revenue is $504.6 million (2023), against an average of $496.6 million.
  • Across the five-year window, Non-Current Deffered Revenue declined 10.71% in 2024 and climbed 18.32% in 2026, its largest moves.
  • Year by year, Non-Current Deffered Revenue stood at $525.4 million in 2022, then declined by 3.96% to $504.6 million in 2023, then fell by 8.73% to $460.6 million in 2024, then increased by 15.76% to $533.1 million in 2025, then fell by 3.82% to $512.8 million in 2026.
  • Per Business Quant, the three latest PHG Non-Current Deffered Revenue figures stand at $512.8 million (Q1 2026), $533.1 million (Q4 2025), and $485.2 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 512.79 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Steris 20.59 Bn 20.16 Bn 697.10 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 512.79 Mn
Dec 31, 2025 533.13 Mn
Sep 30, 2025 485.16 Mn
Jun 30, 2025 466.37 Mn
Mar 31, 2025 433.38 Mn
Dec 31, 2024 460.56 Mn
Jun 30, 2024 480.29 Mn
Dec 31, 2023 504.62 Mn
Jun 30, 2023 537.93 Mn
Dec 31, 2022 525.43 Mn
Jun 30, 2022 522.86 Mn
Dec 31, 2021 510.21 Mn
Jun 30, 2021 507.00 Mn
Dec 31, 2020 480.49 Mn
Jun 30, 2020 395.42 Mn
Dec 31, 2019 385.20 Mn
Jun 30, 2019 326.98 Mn
Dec 31, 2018 257.96 Mn
Jun 30, 2018 263.75 Mn
Dec 31, 2017 293.18 Mn